InVitro International

Total Valuation

InVitro International carries a market capitalization of 1.83M, placing it among publicly traded companies globally. Its enterprise value stands at 1.02M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

InVitro International currently has 22.26M shares outstanding.

Valuation Ratios

InVitro International trades at a trailing price-to-earnings ratio of 19.69. The price-to-sales ratio is 2.40, and the price-to-book ratio stands at 1.25.

Enterprise Valuation

On an enterprise value basis, InVitro International trades at an EV/EBITDA multiple of 12.65 and an EV/FCF ratio of 69.01. The EV/Sales ratio of 1.24 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 14.38 provides insight into valuation relative to core operating earnings.

Financial Position

InVitro International maintains a current ratio of 12.37, meaning it holds 12.4x the short-term assets needed to cover near-term liabilities.

Financial Efficiency

InVitro International posts a return on equity of 6.41 and a return on invested capital of 3.58.

Taxes

Over the trailing twelve months, InVitro International has paid 2,589.00 in income taxes, reflecting an effective tax rate of 2.50.

Stock Price Statistics

InVitro International's stock has gained approximately 37.16667% over the past 52 weeks. The 50-day moving average sits at 0.08, while the 200-day moving average is 0.09.

Income Statement

Over the trailing twelve months, InVitro International generated 827,727.00 in revenue and converted that into 100,900.00 in net income, yielding earnings per share of 0.00. EBITDA reached 80,927.00, while operating income came in at 71,186.00.

Balance Sheet

InVitro International holds 1.22M in cash and equivalents against 256,068.00 in total debt, resulting in a net debt position of -1.22M. Total book value stands at 1.59M, with working capital of 1.39M providing operational flexibility.

Cash Flow

InVitro International produced 14,836.00 in operating cash flow over the past twelve months.

Margins

InVitro International operates with a gross margin of 81.83, reflecting its pricing power and cost economics. The operating margin of 8.60 and net profit margin of 12.19 provide insight into operational efficiency.

Dividends & Yields

Scores

InVitro International posts an Altman Z-Score of 5.88, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.